Search research articles
Contact Us
Filters
Showing results (231-240 of 255) with videos related to
Page
of 26
Sort By:
JAMA
|
July 27, 2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial
Paul D Brown, Kurt Jaeckle, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
Evanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Journal of Neuro-Oncology
|
January 12, 2010
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Kurt A Jaeckle, Karla V Ballman, Caterina Giannini, et al.
Neuro-Oncology
|
October 11, 2017
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Jann N Sarkaria, Leland S Hu, Ian F Parney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
Christopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
Scientific Reports
|
May 29, 2019
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway
Elizabeth K Benedikz, Dalan Bailey, Charlotte N L Cook, et al.
Page
of 26
Search research articles
Search
Showing results (231-240 of 255) with videos related to
Sort By:
Page
of 26
JAMA
|
July 27, 2016
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial
Paul D Brown, Kurt Jaeckle, Karla V Ballman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 25, 2009
Phase II trial of vorinostat in recurrent glioblastoma multiforme: a north central cancer treatment group study
Evanthia Galanis, Kurt A Jaeckle, Matthew J Maurer, et al.
Journal of Neuro-Oncology
|
January 12, 2010
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM
Kurt A Jaeckle, Karla V Ballman, Caterina Giannini, et al.
Neuro-Oncology
|
October 11, 2017
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data
Jann N Sarkaria, Leland S Hu, Ian F Parney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177
Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
Christopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
Neuro-Oncology
|
October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02
Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
The Lancet. Oncology
|
July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
Paul D Brown, Karla V Ballman, Jane H Cerhan, et al.
The New England Journal of Medicine
|
April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
Scientific Reports
|
May 29, 2019
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathway
Elizabeth K Benedikz, Dalan Bailey, Charlotte N L Cook, et al.
Page
of 26